SEC Form 4 · accession 0001562180-17-000486
Dermira, Inc. · DERM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Wiggans
Officer — CEO & Chairman of the Board · Director
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2017 | M | 5,000 | $0.986 | A | 11,468 | D | |
| Common StockF2 | Feb 1, 2017 | S | 4,796 | $29.3258 | D | 6,672 | D | |
| Common StockF3,F4 | Feb 1, 2017 | S | 204 | $29.9896 | D | 6,468 | D | |
| Common StockF5 | holding | — | — | — | 134,180 | I | By the Wiggans Living Trust dated 5/14/02 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F6 | $0.986 | Feb 1, 2017 | M | 5,000 | A | — | Oct 3, 2021 | Common Stock | 5,000 | 240,642 | D |
Explanation of responses
- F1These trades were made pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $28.96 to $29.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $29.97 to $30.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4These shares include prior ESPP purchases.
- F5The Reporting Person is a Co-Trustee.
- F6This option fully vested on 10/04/2015.